User menu

5q14.3 neurocutaneous syndrome: a novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C.

Bibliographic reference Carr, Christopher W ; Zimmerman, Holly H ; Martin, Christa Lese ; Vikkula, Miikka ; Byrd, Adam C ; et. al. 5q14.3 neurocutaneous syndrome: a novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C.. In: American Journal of Medical Genetics. Part A, Vol. 155A, no.7, p. 1640-5 (2011)
Permanent URL http://hdl.handle.net/2078.1/120172
  1. Baldwin Erin L, Lee Ji-Yun, Blake Douglas M, Bunke Brian P, Alexander Chad R, Kogan Amy L, Ledbetter David H, Martin Christa L, Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray, 10.1097/gim.0b013e318177015c
  2. Boon Laurence M, Mulliken John B, Vikkula Miikka, RASA1: variable phenotype with capillary and arteriovenous malformations, 10.1016/j.gde.2005.03.004
  3. Cardoso C., Boys A., Parrini E., Mignon-Ravix C., McMahon J. M., Khantane S., Bertini E., Pallesi E., Missirian C., Zuffardi O., Novara F., Villard L., Giglio S., Chabrol B., Slater H. R., Moncla A., Scheffer I. E., Guerrini R., Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion, 10.1212/01.wnl.0000336339.08878.2d
  4. Clark G. J., Quilliam L. A., Hisaka M. M., Der C. J., Differential antagonism of Ras biological activity by catalytic and Src homology domains of Ras GTPase activation protein., 10.1073/pnas.90.11.4887
  5. Eerola Iiro, Boon Laurence M., Mulliken John B., Burrows Patricia E., Dompmartin Anne, Watanabe Shoji, Vanwijck Romain, Vikkula Miikka, Capillary Malformation–Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 Mutations, 10.1086/379793
  6. Eki Toshihiko, Okumura Katsuzumi, Abe Makoto, Kagotani Kazuhiro, Taguchi Hiroshi, Murakami Yasufumi, Pan Zhen-Qiang, Hanaoka Fumio, Mapping of the Human Genes Encoding Cyclin H (CCNH) and the CDK-Activating Kinase (CAK) Assembly Factor MAT1 (MNAT1) to Chromosome Bands 5q13.3–q14 and 14q23, Respectively, 10.1006/geno.1997.5053
  7. Engels Hartmut, Wohlleber Eva, Zink Alexander, Hoyer Juliane, Ludwig Kerstin U, Brockschmidt Felix F, Wieczorek Dagmar, Moog Ute, Hellmann-Mersch Birgit, Weber Ruthild G, Willatt Lionel, Kreiß-Nachtsheim Martina, Firth Helen V, Rauch Anita, A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients, 10.1038/ejhg.2009.90
  8. Ezugha Herbert, Goldenthal Michael, Valencia Ignacio, Anderson Carol E., Legido Agustin, Marks Harold, 5q14.3 Deletion Manifesting as Mitochondrial Disease and Autism: Case Report, 10.1177/0883073809361165
  9. Hershkovitz D., Bercovich D., Sprecher E., Lapidot M., RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations, 10.1111/j.1365-2133.2008.08493.x
  10. Iafrate A John, Feuk Lars, Rivera Miguel N, Listewnik Marc L, Donahoe Patricia K, Qi Ying, Scherer Stephen W, Lee Charles, Detection of large-scale variation in the human genome, 10.1038/ng1416
  11. Kleinjan Dirk A., van Heyningen Veronica, Long-Range Control of Gene Expression: Emerging Mechanisms and Disruption in Disease, 10.1086/426833
  12. Lancet D Safran M Olender T Dalah I Iny-Stein T Inger A Harel A Stelzer G 2008 GeneCards tools for combinatorial annotation and dissemination of human genome information. GIACS Conference on Data in Complex Systems http://www.genecards.org
  13. Le Meur N., Holder-Espinasse M., Jaillard S., Goldenberg A., Joriot S., Amati-Bonneau P., Guichet A., Barth M., Charollais A., Journel H., Auvin S., Boucher C., Kerckaert J.-P., David V., Manouvrier-Hanu S., Saugier-Veber P., Frebourg T., Dubourg C., Andrieux J., Bonneau D., MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations, 10.1136/jmg.2009.069732
  14. Limaye N., Boon L. M., Vikkula M., From germline towards somatic mutations in the pathophysiology of vascular anomalies, 10.1093/hmg/ddp002
  15. Novara F, Beri S, Giorda R, Ortibus E, Nageshappa S, Darra F, Dalla Bernardina B, Zuffardi O, Van Esch H, Refining the phenotype associated withMEF2Chaploinsufficiency, 10.1111/j.1399-0004.2010.01413.x
  16. Nowakowska, Am J Med Genet B Neuropsychiatr Genet, 153B, 1042 (2010)
  17. Potthoff Matthew J., Wu Hai, Arnold Michael A., Shelton John M., Backs Johannes, McAnally John, Richardson James A., Bassel-Duby Rhonda, Olson Eric N., Histone deacetylase degradation andMEF2 activation promote the formation of slow-twitch myofibers, 10.1172/jci31960
  18. Revencu Nicole, Boon Laurence M., Mulliken John B., Enjolras Odile, Cordisco Maria Rosa, Burrows Patricia E., Clapuyt Philippe, Hammer Frank, Dubois Josée, Baselga Eulalia, Brancati Francesco, Carder Robin, Quintal José Miguel Ceballos, Dallapiccola Bruno, Fischer Gayle, Frieden Ilona J., Garzon Maria, Harper John, Johnson-Patel Jennifer, Labrèze Christine, Martorell Loreto, Paltiel Harriet J., Pohl Annette, Prendiville Julie, Quere Isabelle, Siegel Dawn H., Valente Enza Maria, Van Hagen Annet, Van Hest Liselot, Vaux Keith K., Vicente Asuncion, Weibel Lisa, Chitayat David, Vikkula Miikka, Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutations, 10.1002/humu.20746
  19. Thiex R., Mulliken J. B., Revencu N., Boon L. M., Burrows P. E., Cordisco M., Dwight Y., Smith E. R., Vikkula M., Orbach D. B., A Novel Association between RASA1 Mutations and Spinal Arteriovenous Anomalies, 10.3174/ajnr.a1907
  20. Zweier Markus, Gregor Anne, Zweier Christiane, Engels Hartmut, Sticht Heinrich, Wohlleber Eva, Bijlsma Emilia K., Holder Susan E., Zenker Martin, Rossier Eva, Grasshoff Ute, Johnson Diana S., Robertson Lisa, Firth Helen V., Cornelia Kraus, Ekici Arif B., Reis André, Rauch Anita, Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression, 10.1002/humu.21253